overview of the clinical management of patients with mf
Published 2 months ago • 70 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
2:41
an overview of the latest advances in hematology
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
5:11
an overview of the aims & work of the adwp
-
4:54
beakertv | meet brenda montgomery, msl at biomea fusion
-
21:38
drawing the line: the rationale behind blood tube collection order
-
1:08:47
michael porter on "value based health care delivery"
-
1:18
considering age and disease characteristics in the risk stratification and management of wm
-
0:47
the potential of early intervention for high-risk patients with waldenström's macroglobulinemia
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
18:51
healthcare reform and hematology – the value of a laboratory and pathology utilization program
-
1:25
advances in targeted therapies and combination approaches for the treatment of cll
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
0:47
overview of the phase iii enhance trial schema
-
2:16
the current state-of-the-art in mf and pv therapy and future outlooks
-
1:20
the impact of early ruxolitinib treatment on os in the comfort-i and comfort-ii studies
-
1:39
session highlights: the value of clinical hematology research groups
-
1:54
the modified risk stratification of wm: integrating older age, abnormal ldh, and low albumin